Tolerance Bio
Philadelphia, US · Founded 2023 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
PB
Philip BallExecutive Officer, Director
DT
Damia Tormo CarullaDirector
JV
Justin VogelExecutive Officer, Director
FL
Francisco LeonExecutive Officer, Director
RG
Robert GoldsteinDirector
PC
Pablo CironiDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$15.1MraisedJun 2026 · 13 investors · BiotechnologyRule 506(b)
▶$15.1MraisedJun 2026 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip BallExecutive Officer, Director
- Damia Tormo CarullaDirector
- Justin VogelExecutive Officer, Director
- Francisco LeonExecutive Officer, Director
- Pablo CironiDirector
- Robert GoldsteinDirector
- Amount sold
- $15.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Tolerance Bio has filed a notice of an exempt offering of securities to raise $15,101,584.00 in New Funding. - intelligence360intelligence360.news · 2026
- Tolerance Bio Raises $15.1M to Advance a New Vision for Immune Tolerance | BioBuzzbiobuzz.io · 2026
- Tolerance Bio raises $15.1M, backers include Beyond Celiac - Philadelphia Business Journalbizjournals.com · 2026
- Beyond Celiac Investments Announces Investment in Tolerance Bio to Advance Novel Approach in Celiac Disease | BeyondCeliac.orgbeyondceliac.org · 2026
